Research Snappy
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News
No Result
View All Result
Research Snappy
No Result
View All Result

2020 is 3 days old and drug prices are already jumping

researchsnappy by researchsnappy
January 4, 2020
in Consumer Research
0
2020 is 3 days old and drug prices are already jumping
399
SHARES
2.3k
VIEWS
Share on FacebookShare on Twitter

Video by CBS Sacramento

Pharmaceutical firms are making it hard for President Donald Trump to fulfill his promise to address runaway prescription drug prices. Three days into the new year, drugmakers have already increased the list prices on hundreds of medications, with experts predicting more hikes in the weeks to come. 

So far in 2020, prices on 411 drugs have increased an average of 5%, according to GoodRx, which tracks the cost of more than 3,500 drugs. Of the drugs that have seen rising prices, 407 were brand-name products and four were generic. 

The drug with the biggest cost increase so far this year: Neos Therapeutics’ Cotempla XR, a stimulant used to treat ADHD and narcolepsy, whose list price is up more than 13%. Other commonly prescribed drugs that are getting pricier include Eliquis (up 6%), often prescribed to prevent blood clots, and Humira (7.4%), used to treat inflammation in patients with autoimmune disease.

a close up of a logo© Provided by CBS News

Drug prices are much higher in the U.S. than in other wealthy countries, where governments typically negotiate with manufacturers to control costs.

Loading...

Load Error

The Trump Administration last month announced a proposal to import prescription drugs from Canada in an effort to lower costs for consumers. But political barriers could sideline the plan, including opposition from the Canadian government and drug companies.

Still, experts commended the policy’s goal of reducing drug costs in the U.S., where 1 in 8 individuals can’t afford the heart disease medication they need to stay alive. 

Business as usual

The January jump in drug costs is no surprise, with many businesses hiking prices early in the year. Last January, drugmakers raised prices on 486 brand-name drugs by an average of 5.2%. In 2018, 580 brand drugs increased by an average of 8%. Virtually all of those hikes occurred in the first five days of the month, according to GoodRx. 

That could change this year as more pharmaceutical firms delay pushing up prices until later in January, perhaps to avoid scrutiny given the heated political debate around prescription drug costs.

“Obviously, 2019 was a year of tremendous political pressure on drug companies and there was a lot of anticipation Washington was going to do something, so it makes sense they might be more sensitive to coverage or perceptions on their price hikes,” said Thomas Goetz, head of research at GoodRx.

Price hikes will hit consumers

Consumers typically don’t take a direct hit when the list price on prescription drugs rise, with Goetz noting that insurance companies absorb the bulk of the costs. Still, the expenses trickle down to consumers in other ways. 

Insurers can opt to cover fewer drugs, for example, curbing patient access to expensive brand-name drugs. “They become more restrictive with the list of drugs they cover,” he said. 

Firms also can make consumers jump through hoops to access those drugs that are covered by insurance. Patients are often required to obtain prior authorization before their insurer agrees to pay for a drug, which can be discouraging. Patients responsible for coinsurance — a percentage of a drug’s cost rather than a fixed amount — are also hit hard by increases in drugs’ list prices.

“If you pay 10% of a $4,000 drug and that drug goes up 5% or 10%  that’s a meaningful increase,” Goetz said. 

Previous Post

Letters to the editor for Jan. 2, 2020 – Opinion – The Ledger

Next Post

Car Sales Remain Strong as Buyers Absorb Higher Prices

Next Post
Car Sales Remain Strong as Buyers Absorb Higher Prices

Car Sales Remain Strong as Buyers Absorb Higher Prices

Research Snappy

Category

  • Advertising Research
  • Consumer Research
  • Data Analysis
  • Healthcare Research
  • Investment Research
  • News

Pa. Republicans reconsider Pitt funding over fetal tissue research, college voucher program

Arthur Pharma Closes Series A Financing Round

YouTube and the Achilles Tendon: An Analysis of Internet Information Reliability and Content Quality

  • Privacy Policy
  • Terms of Use
  • Antispam
  • DMCA
  • Contact Us

© 2022 researchsnappy.com

No Result
View All Result
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News

© 2022 researchsnappy.com